Transmembrane protease serine 5: a novel Schwann cell plasma marker for CMT1A

Transmembrane protease serine 5: a novel Schwann cell plasma marker for CMT1A

Abstract Objective Development of biomarkers for Charcot‐Marie‐Tooth (CMT) disease is critical for implementing effective clinical trials. The most common form of CMT, type 1A, is caused by a genomic duplication surrounding the PMP22 gene. A recent report (Neurology 2018;90:e518–3524) showed elevati...

Full description

Bibliographic Details
Main Authors: Hongge Wang, Matthew Davison, Kathryn Wang, Tai‐He Xia, Martin Kramer, Katherine Call, Jun Luo, Xingyao Wu, Riccardo Zuccarino, Chelsea Bacon, Yunhong Bai, John J. Moran, Laurie Gutmann, Shawna M. E. Feely, Tiffany Grider, Alexander M. Rossor, Mary M. Reilly, John Svaren, Michael E. Shy
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Annals of Clinical and Translational Neurology
Online Access:https://doi.org/10.1002/acn3.50965

Internet

https://doi.org/10.1002/acn3.50965

Similar Items